Twist Bioscience stock jumps 5.44% after supporting Wallace UCSF mRNA research, Twist Bioscience says

Twist Bioscience stock jumps 5.44% after supporting Wallace UCSF mRNA research, Twist Bioscience says
Twist Bioscience surges 5.44% today

Twist Bioscience reported that its DNA products supported research published on genome-wide analysis of mRNA regionalization in a giant single cell.

Highlights

  • TWST maintains a strong uptrend, trading well above key support levels and forming new 52-week highs.
  • Technical indicators signal sustained bullish momentum, but elevated overbought readings suggest a notable risk of short-term consolidation.
  • TWST is expected to trade within $84.50 to $106.50 next week, with an over 80% probability of continued upside unless a sudden drop below $84.50 signals a pullback.

The company thanked WallaceUcsf and their team for choosing Twist DNA for work in the mentioned paper. The study appeared in PNAS.

Bullish dominance as price holds above major moving averages and key support

TWST is trading well above its key moving averages, with the current price of $96.32 above the MA-20 at $75.47, the MA-50 at $64.75, and the MA-200 at $44.11, confirming strong bullish momentum across short, medium, and long-term trends. The Ichimoku Kijun level stands at $70.86, which now acts as immediate support. The nearest support levels are found at the Ichimoku Kijun ($70.86) as near-term support and the MA-50 ($64.75) as key support, while resistance is indicated by the recent 52-week high at $93.80 (near-term) and the psychological round number of $100 as the next potential resistance cluster.

Overbought signals emerge as momentum persists near resistance

Momentum remains firmly positive, as both MACD and ADX on D1 signal a robust uptrend. However, overbought readings are apparent: RSI is elevated at 74.46, Stoch RSI sits at 94.98, and CCI is at 142.33, suggesting the rally is stretched. BBP reflects strong buyer dominance intraday. The Awesome Oscillator supports continued bullish sentiment. In today’s session, the stock advanced 5.44%, surging toward the upper end of its daily range. Over the past week, TWST has climbed 9.88%, moving from $87.56 to $96.32, now sitting at the very top of its weekly range as volatility stands at 15.02%. This sharp weekly gain and strong close near resistance highlight strong buying pressure but also heighten the risk of near-term consolidation or retracement.

High breakout odds as bullish structure narrows trading range

For the coming week, TWST is expected to fluctuate between $84.50 and $106.50, based on current volatility and recent price action—anchoring this range near its 52-week high of $93.80 and well above its 52-week low of $23.30. The probability of a further price increase is very high (more than 80%), given that W1 indicators (RSI, ADX, MACD, MA-50) all show bullish forecasts, making further declines less likely. The baseline scenario projects sideways movement within this elevated band. A bullish breakout above $100 could extend the advance toward new highs. Conversely, a bearish scenario would require a dip below $84.50, signaling the start of a potential pullback, though the overall trend remains firmly upward.

Previously it was reported that Twist Bioscience was exhibiting strong bullish momentum, with technical signals pointing toward continued upside and limited short-term downside risk. This article adds a fresh perspective, highlighting the prevailing scenario for TWST and identifying a key level that traders should monitor as the outlook evolves.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.